Advertisement

Loading...

Australis Capital Inc.

AUSA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
Canadian Market opens in 16h 26m

Australis Capital Inc. Fundamental Analysis

Australis Capital Inc. (AUSA.CN) shows weak financial fundamentals with a PE ratio of -0.15, profit margin of -5.29%, and ROE of -1.15%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00

Areas of Concern

ROE-1.15%
Operating Margin-2.56%
Current Ratio0.69
We analyze AUSA.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -618.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-618.2/100

We analyze AUSA.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

AUSA.CN struggles to generate sufficient returns from assets.

ROA > 10%
-79.10%

Valuation Score

Excellent

AUSA.CN trades at attractive valuation levels.

PE < 25
-0.15
PEG Ratio < 2
-0.00

Growth Score

Weak

AUSA.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

AUSA.CN shows balanced financial health with some risks.

Debt/Equity < 1
0.66
Current Ratio > 1
0.69

Profitability Score

Weak

AUSA.CN struggles to sustain strong margins.

ROE > 15%
-114.84%
Net Margin ≥ 15%
-5.29%
Positive Free Cash Flow
No

Key Financial Metrics

Is AUSA.CN Expensive or Cheap?

P/E Ratio

AUSA.CN trades at -0.15 times earnings. This suggests potential undervaluation.

-0.15

PEG Ratio

When adjusting for growth, AUSA.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Australis Capital Inc. at 0.30 times its book value. This may indicate undervaluation.

0.30

EV/EBITDA

Enterprise value stands at 0.39 times EBITDA. This is generally considered low.

0.39

How Well Does AUSA.CN Make Money?

Net Profit Margin

For every $100 in sales, Australis Capital Inc. keeps $-5.29 as profit after all expenses.

-5.29%

Operating Margin

Core operations generate -2.56 in profit for every $100 in revenue, before interest and taxes.

-2.56%

ROE

Management delivers $-1.15 in profit for every $100 of shareholder equity.

-1.15%

ROA

Australis Capital Inc. generates $-79.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

-79.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Australis Capital Inc. generates limited operating cash flow of $-14.21M, signaling weaker underlying cash strength.

$-14.21M

Free Cash Flow

Australis Capital Inc. generates weak or negative free cash flow of $-14.21M, restricting financial flexibility.

$-14.21M

FCF Per Share

Each share generates $-0.05 in free cash annually.

$-0.05

FCF Yield

AUSA.CN converts -1.46% of its market value into free cash.

-1.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.15

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.03

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.66

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.15

vs 25 benchmark

ROA

Return on assets percentage

-0.79

vs 25 benchmark

ROCE

Return on capital employed

-0.48

vs 25 benchmark

How AUSA.CN Stacks Against Its Sector Peers

MetricAUSA.CN ValueSector AveragePerformance
P/E Ratio-0.1527.91 Better (Cheaper)
ROE-114.84%687.00% Weak
Net Margin-528.67%-45285.00% (disorted) Weak
Debt/Equity0.660.33 Weak (High Leverage)
Current Ratio0.692795.76 Weak Liquidity
ROA-79.10%-13557.00% (disorted) Weak

AUSA.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Australis Capital Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ